Urinary microbiota and serum metabolite analysis in patients with diabetic kidney disease

[1]  Ying Luo,et al.  Metabolomics analysis of human plasma reveals decreased production of trimethylamine N‐oxide retards the progression of chronic kidney disease , 2022 .

[2]  Ruiyan Zhang,et al.  Intestinal Microbiota-Derived Short Chain Fatty Acids in Host Health and Disease , 2022, Nutrients.

[3]  Dayong Hu,et al.  Multiple techniques collectively reveal the attenuation of kidney injury by trimethylamine N-oxide (TMAO) production manipulation. , 2022, British journal of pharmacology.

[4]  Lisa C. Crossman,et al.  Microbiomes of Urine and the Prostate Are Linked to Human Prostate Cancer Risk Groups. , 2022, European urology oncology.

[5]  R. Link,et al.  The Microbiome and Urolithiasis: Current Advancements and Future Challenges , 2022, Current Urology Reports.

[6]  D. Magana-Arachchi,et al.  Dysbiosis of the Human Urinary Microbiome and its Association to Diseases Affecting the Urinary System , 2021, Indian Journal of Microbiology.

[7]  W. van Biesen,et al.  Gut Microbiota and Their Derived Metabolites, a Search for Potential Targets to Limit Accumulation of Protein-Bound Uremic Toxins in Chronic Kidney Disease , 2021, Toxins.

[8]  Haixue Lin,et al.  The change of gut microbiota‐derived short‐chain fatty acids in diabetic kidney disease , 2021, Journal of clinical laboratory analysis.

[9]  W. Załuska,et al.  A Link between Chronic Kidney Disease and Gut Microbiota in Immunological and Nutritional Aspects , 2021, Nutrients.

[10]  Chi-Chang Huang,et al.  Effectiveness of human-origin Lactobacillus plantarum PL-02 in improving muscle mass, exercise performance and anti-fatigue , 2021, Scientific Reports.

[11]  A. Maiti.  Development of Biomarkers and Molecular Therapy Based on Inflammatory Genes in Diabetic Nephropathy , 2021, International journal of molecular sciences.

[12]  C. Pollock,et al.  The Role of the Gut Microbiome in Diabetes and Obesity-Related Kidney Disease , 2021, International journal of molecular sciences.

[13]  T. Spector,et al.  The gut microbiome: what the oncologist ought to know , 2021, British Journal of Cancer.

[14]  Qing Fang,et al.  Trimethylamine N-Oxide Exacerbates Renal Inflammation and Fibrosis in Rats With Diabetic Kidney Disease , 2021, Frontiers in Physiology.

[15]  Qing Fang,et al.  Roles of Gut Microbial Metabolites in Diabetic Kidney Disease , 2021, Frontiers in Endocrinology.

[16]  L. Peixe,et al.  Long-term stability of the urogenital microbiota of asymptomatic European women , 2021, BMC microbiology.

[17]  M. Kanbay,et al.  Intestinal microbiota and diabetic kidney diseases: the Role of microbiota and derived metabolites inmodulation of renal inflammation and disease progression. , 2021, Best practice & research. Clinical endocrinology & metabolism.

[18]  J. Doré,et al.  Introduction to host microbiome symbiosis in health and disease , 2020, Mucosal Immunology.

[19]  P. J. Larsen,et al.  The Novel Phosphate and Bile Acid Sequestrant Polymer SAR442357 Delays Disease Progression in a Rat Model of Diabetic Nephropathy , 2020, The Journal of Pharmacology and Experimental Therapeutics.

[20]  Minoru Kanehisa,et al.  KEGG: integrating viruses and cellular organisms , 2020, Nucleic Acids Res..

[21]  Hiren V. Patel,et al.  The human microbiome and genitourinary malignancies , 2020, Annals of translational medicine.

[22]  M. Nieuwdorp,et al.  Gut Microbiota in Hypertension and Atherosclerosis: A Review , 2020, Nutrients.

[23]  P. Savelkoul,et al.  How to Count Our Microbes? The Effect of Different Quantitative Microbiome Profiling Approaches , 2020, Frontiers in Cellular and Infection Microbiology.

[24]  Kyung Lee,et al.  Diabetic Kidney Disease: Challenges, Advances, and Opportunities , 2020, Kidney Diseases.

[25]  Oliver Fiehn,et al.  A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors , 2020, Cell.

[26]  Dongsun Park,et al.  Lactobacillus salivarius BP121 prevents cisplatin-induced acute kidney injury by inhibition of uremic toxins such as indoxyl sulfate and p-cresol sulfate via alleviating dysbiosis , 2020, International journal of molecular medicine.

[27]  L. Appel,et al.  Effects of high-fiber diets enriched with carbohydrate, protein, or unsaturated fat on circulating short chain fatty acids: results from the OmniHeart randomized trial. , 2020, The American journal of clinical nutrition.

[28]  L. Chang,et al.  Gut Microbiota as Diagnostic Tools for Mirroring Disease Progression and Circulating Nephrotoxin Levels in Chronic Kidney Disease: Discovery and Validation Study , 2020, International journal of biological sciences.

[29]  R. Rodrigues,et al.  Role of gut microbiota in type 2 diabetes pathophysiology , 2020, EBioMedicine.

[30]  Minoru Kanehisa,et al.  Toward understanding the origin and evolution of cellular organisms , 2019, Protein science : a publication of the Protein Society.

[31]  R. Fichorova,et al.  The Current Evidence on the Association Between the Urinary Microbiome and Urinary Incontinence in Women , 2019, Front. Cell. Infect. Microbiol..

[32]  Nayoung Kim,et al.  Gut microbiota and butyrate level changes associated with the long-term administration of proton pump inhibitors to old rats , 2019, Scientific Reports.

[33]  T. Abe,et al.  Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease , 2019, Nature Communications.

[34]  Xiaoxi Zeng,et al.  Understanding the gut–kidney axis among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls: an analysis of the gut microbiota composition , 2019, Acta Diabetologica.

[35]  L. Dițu,et al.  Gut Microbiota, Host Organism, and Diet Trialogue in Diabetes and Obesity , 2019, Front. Nutr..

[36]  T. Wong,et al.  Association of Diabetic Retinopathy and Diabetic Kidney Disease With All-Cause and Cardiovascular Mortality in a Multiethnic Asian Population , 2019, JAMA network open.

[37]  Douglas E Schaubel,et al.  US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States. , 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[38]  E. Elbassuoni,et al.  Evidence of the protective effect of l-arginine and vitamin D against monosodium glutamate-induced liver and kidney dysfunction in rats. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[39]  F. Milagro,et al.  Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target , 2018, Nutrients.

[40]  T. Meyer,et al.  Characteristics of Colon-Derived Uremic Solutes. , 2018, Clinical journal of the American Society of Nephrology : CJASN.

[41]  D. Raj,et al.  Gut Microbiota and Cardiovascular Uremic Toxicities , 2018, Toxins.

[42]  H. Tilg,et al.  The Intestinal Microbiota in Colorectal Cancer. , 2018, Cancer cell.

[43]  N. Vaziri,et al.  The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus , 2018, International Urology and Nephrology.

[44]  Michael J. Zilliox,et al.  Diversity of the midstream urine microbiome in adults with chronic kidney disease , 2018, International Urology and Nephrology.

[45]  Xinhua Xiao,et al.  Inulin-type fructan improves diabetic phenotype and gut microbiota profiles in rats , 2018, PeerJ.

[46]  J. Latorre,et al.  Gut Microbiota Interacts with Markers of Adipose Tissue Browning, Insulin Action and Plasma Acetate in Morbid Obesity , 2018, Molecular nutrition & food research.

[47]  P. Fu,et al.  Gut microbiota–derived short-chain fatty acids and kidney diseases , 2017, Drug design, development and therapy.

[48]  Guangping Sun,et al.  Gut microbial metabolite TMAO contributes to renal dysfunction in a mouse model of diet-induced obesity. , 2017, Biochemical and biophysical research communications.

[49]  L. Brubaker,et al.  The female urinary microbiota, urinary health and common urinary disorders. , 2017, Annals of translational medicine.

[50]  Alexander E. Kel,et al.  cutPrimers: A New Tool for Accurate Cutting of Primers from Reads of Targeted Next Generation Sequencing , 2017, J. Comput. Biol..

[51]  L. Brubaker,et al.  Female urinary microbiota , 2017, Current opinion in urology.

[52]  Yonghong Xiao,et al.  Alterations of Urinary Microbiota in Type 2 Diabetes Mellitus with Hypertension and/or Hyperlipidemia , 2017, Front. Physiol..

[53]  S. Lynch,et al.  The Human Intestinal Microbiome in Health and Disease. , 2016, The New England journal of medicine.

[54]  D. Kuypers,et al.  Microbiota-Derived Phenylacetylglutamine Associates with Overall Mortality and Cardiovascular Disease in Patients with CKD. , 2016, Journal of the American Society of Nephrology : JASN.

[55]  Paul J. McMurdie,et al.  DADA2: High resolution sample inference from Illumina amplicon data , 2016, Nature Methods.

[56]  J. Moliz,et al.  l-Arginine metabolism in cardiovascular and renal tissue from hyper- and hypothyroid rats , 2016, Experimental biology and medicine.

[57]  R. Talukdar,et al.  Role of the normal gut microbiota. , 2015, World journal of gastroenterology.

[58]  T. Spector,et al.  Gut-Microbiota-Metabolite Axis in Early Renal Function Decline , 2015, PloS one.

[59]  L. Brubaker,et al.  "Sterile Urine" and the Presence of Bacteria. , 2015, European urology.

[60]  P. Tessari.  Nitric oxide in the normal kidney and in patients with diabetic nephropathy , 2015, Journal of Nephrology.

[61]  A. Popolo,et al.  l-Arginine and its metabolites in kidney and cardiovascular disease , 2014, Amino Acids.

[62]  Björn Usadel,et al.  Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..

[63]  Michael J. Zilliox,et al.  Urine Is Not Sterile: Use of Enhanced Urine Culture Techniques To Detect Resident Bacterial Flora in the Adult Female Bladder , 2013, Journal of Clinical Microbiology.

[64]  Robert C. Edgar,et al.  UPARSE: highly accurate OTU sequences from microbial amplicon reads , 2013, Nature Methods.

[65]  G. Andersen,et al.  Chronic kidney disease alters intestinal microbial flora. , 2013, Kidney international.

[66]  Inger Ljungberg,et al.  Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury , 2012, Journal of Translational Medicine.

[67]  K. Nelson,et al.  Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury , 2012, Journal of Translational Medicine.

[68]  C. Huttenhower,et al.  Metagenomic biomarker discovery and explanation , 2011, Genome Biology.

[69]  Joshua D. Knowles,et al.  Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry , 2011, Nature Protocols.

[70]  D. Relman,et al.  Assembly of the human intestinal microbiota. , 2006, Trends in ecology & evolution.

[71]  S. Wold,et al.  Orthogonal projections to latent structures (O‐PLS) , 2002 .

[72]  E. Lukacz,et al.  Evaluation of the urinary microbiota of women with uncomplicated stress urinary incontinence , 2017, American journal of obstetrics and gynecology.

[73]  B. Fernández-Fernández,et al.  Identification of a urine metabolomic signature in patients with advanced-stage chronic kidney disease. , 2014, Kidney international.

[74]  S. Salzberg,et al.  FLASH: fast length adjustment of short reads to improve genome assemblies , 2011, Bioinform..

[75]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..